GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated December 11, 2025, serves as a transaction notification for Persons Discharging Managerial Responsibilities (PDMRs). The report covers share acquisition activities conducted on December 9, 2025, on the London Stock Exchange (XLON) under the Company's Share Reward Plan.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a regulatory disclosure of insider share transactions.
Material Changes and Transaction Details
Eight senior executives acquired Ordinary Shares (ISIN: GB00BN7SWP63) at a uniform price of £18.0780 per share. The transactions consisted of partnership shares and matching shares. The specific volumes were:
- Emma Walmsley (CEO): 14 shares (7 partnership, 7 matching)
- Julie Brown (CFO): 12 shares (6 partnership, 6 matching)
- James Ford (SVP, Legal): 12 shares (6 partnership, 6 matching)
- Sally Jackson (SVP, Communications): 14 shares (7 partnership, 7 matching)
- David Redfern (President, Corporate Development): 14 shares (7 partnership, 7 matching)
- Regis Simard (President, Global Supply Chain): 14 shares (7 partnership, 7 matching)
- Philip Thomson (President, Global Affairs): 14 shares (7 partnership, 7 matching)
- Deborah Waterhouse (CEO, ViiV Healthcare): 14 shares (7 partnership, 7 matching)
- Victoria Whyte (SVP & Company Secretary): 14 shares (7 partnership, 7 matching)
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. It contains only the statutory details of the share acquisitions.
Investor Verification Checklist
- Verify the total number of shares acquired by PDMRs (86 shares total) against the company's internal share plan records.
- Confirm the transaction price of £18.0780 aligns with the market price on the London Stock Exchange on December 9, 2025.
- Review the full Share Reward Plan terms to understand the vesting schedule and conditions for the partnership and matching shares.
- Note that this filing contains no operational or financial performance data; refer to the latest Form 20-F for comprehensive financial results.